Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a risk score plus a blood test catch dangerous leg clots after heart surgery?

NCT ID NCT06729021

Diagnosis Sponsor: Al-Nahrain University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 17, 2026 · Last updated Sep 18, 2026 · Updated 1 time

Summary

Researchers in Baghdad are studying whether combining the Modified Caprini Score, a checklist of risk factors, with a D-Dimer blood test predicts lower extremity venous thrombosis better than either tool alone in patients recovering from heart and chest surgery. About 112 hospitalized patients will receive both assessments during their stay and be monitored for clots, pulmonary embolism, and other complications. The goal is to see if this combined approach can help doctors decide who needs clot prevention and management.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If the combined approach proves accurate, doctors could better identify which heart and chest surgery patients need clot prevention and which can safely avoid blood thinners.
What could go wrong
This is a small observational study at one hospital in Baghdad, so the findings may not apply to other hospitals or patient groups. The tools being tested are already in use, and the study does not test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 112 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2025

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study will include adult patients (≥18 years old) undergoing cardiothoracic surgery at Kadhimiya Teaching Hospital in Baghdad, with a focus on those at risk for lower extremity venous thrombosis (LEVT).

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Inpatients with a hospital stay over 3 days * Written informed consent obtained from patients or their legal guardians. * Availability for postoperative follow-up to assess outcomes like LEVT development or related complications. Exclusion Criteria: * Preexisting LEVT or Pulmonary Embolism: Diagnosed before the index surgery. * Severe Coagulopathy: Patients with inherited or acquired bleeding disorders (e.g., hemophilia, advanced liver disease). * receiving any anticoagulation therapy for any reason. * patients who did not undergo a postoperative D-dimer test. * Incomplete Data: missing essential clinical or laboratory data for Modified Caprini Score calculation or D-Dimer measurement. * Pregnancy: pregnant women or those within six weeks postpartum. * Noncompliance: Patients unwilling or unable to adhere to study follow-up protocols.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DVT - deep vein thrombosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

venous thromboembolism Venous Thrombosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DVT - deep vein thrombosis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • College of Medicine - Al-Nahrain University

    RECRUITING

    Baghdad, Iraq

More trials for these conditions

Other studies related to the condition(s) this trial covers.